Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
暂无分享,去创建一个
M. Freeman | C. Clish | C. Serhan | N. Chiang | K. Gronert | J. A. O'Brien | Chia Nan | J. A. O’Brien
[1] G. Weissmann,et al. Integrin-dependent homotypic adhesion of neutrophils. Arachidonic acid activates Raf-1/Mek/Erk via a 5-lipoxygenase- dependent pathway. , 1998, The Journal of clinical investigation.
[2] C. Clish,et al. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. , 1998, The Journal of clinical investigation.
[3] F. Sun,et al. Functional properties of guinea pig eosinophil leukotriene B4 receptor. , 1991, Journal of immunology.
[4] C. Clish,et al. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. , 1998, The Journal of pharmacology and experimental therapeutics.
[5] C. Funk,et al. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene , 1994, Nature.
[6] P. Ward,et al. Molecular and Cellular Basis of Inflammation , 1999, Current Inflammation Research.
[7] C. Serhan,et al. Identification of a Human Enterocyte Lipoxin A4 Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 Release , 1998, The Journal of experimental medicine.
[8] G. Weissmann,et al. Release of inflammatory mediators from stimulated neutrophils. , 1980, The New England journal of medicine.
[9] S. Gelman. The Pathophysiology of Aortic Cross-clamping and Unclamping , 1995, Anesthesiology.
[10] C. Serhan. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? , 1997, Prostaglandins.
[11] C. Valeri,et al. Mast cells and leukotrienes mediate neutrophil sequestration and lung edema after remote ischemia in rodents. , 1992, Surgery.
[12] A. Luster,et al. Molecular and Biological Characterization of the Murine Leukotriene B4 Receptor Expressed on Eosinophils , 1998, The Journal of experimental medicine.
[13] C. Funk. Lipid-Mediator-Deficient Mice in Models of Inflammation , 1999 .
[14] C. Serhan,et al. Induction of functional lipoxin A4 receptors in HL-60 cells. , 1993, Blood.
[15] A. Marcus. Aspirin as prophylaxis against colorectal cancer. , 1995, The New England journal of medicine.
[16] R. Perlmutter,et al. The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. , 1995, Blood.
[17] A. Sabirsh,et al. The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] C. Malmsten. Leukotrienes: mediators of inflammation and immediate hypersensitivity reactions. , 1984, Critical reviews in immunology.
[19] Takao Shimizu,et al. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis , 1997, Nature.
[20] B. Samuelsson. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.
[21] R. Doms,et al. Leukotriene Binding, Signaling, and Analysis of HIV Coreceptor Function in Mouse and Human Leukotriene B4Receptor-transfected Cells* , 1999, The Journal of Biological Chemistry.
[22] H. Toh,et al. Molecular evolution of receptors for eicosanoids , 1995, FEBS letters.
[23] C. Serhan,et al. Characterization of human neutrophil and endothelial cell ligand-operated extracellular acidification rate by microphysiometry: impact of reoxygenation. , 1998, The Journal of pharmacology and experimental therapeutics.